Top dividend stocks are capable of delivering above-average returns returns in any type of market. Which dividend stocks are no-brainer buys for retail investors right now? AstraZeneca (NASDAQ: AZN), Merck (NYSE: MRK), and Medtronic (NYSE: MDT) are three elite income stocks that have recession-proof businesses, strong growth prospects, and ample free cash flows.
Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda when the company reports Q4 earnings.
Sanofi (NASDAQ: SNY) and AstraZeneca's (NASDAQ: AZN) application for the respiratory syncytial virus (RSV) vaccine candidate called nirsevimab was recently accepted for review by the U.S. Food and Drug Administration (FDA) as a protective option for all infants. Nirsevimab is known by the trade name Beyfortus in the European Union and the United Kingdom, and the FDA expects to make an approval decision on the RSV vaccine in the third quarter of this year.